Suicide risk in patients with somatization disorder

Crisis
Andrea P Chioqueta, Tore C Stiles

Abstract

The aim of the study was to assess suicide risk in psychiatric outpatients with and without somatization disorder. A total sample of 120 psychiatric outpatients was used in the study, 29 of whom met diagnostic criteria for somatization disorder. The results indicated that somatization disorder was significantly associated with suicide attempts even when the effects of both a comorbid major depressive disorder and a comorbid personality disorder were statistically controlled for. The results suggest that, although a patient meets the criteria for a principal diagnosis of major depressive disorder and/or a personality disorder, it is still of significant importance to decide whether or not the patient also meets the criteria for a somatization disorder in order to more optimally assess suicide risk. The findings highlight the fact that the potential for suicide in patients with somatization disorder should not be overlooked when a diagnosable depressive disorder or personality disorder is not present.

References

Nov 1, 1975·The American Journal of Psychiatry·R KimbleS Agras
Sep 1, 1992·General Hospital Psychiatry·K M RostG R Smith
May 1, 1991·American Journal of Public Health·M SwartzK Smith
Jul 1, 1991·Archives of General Psychiatry·C Allgulander, P W Lavori
May 11, 1991·Journal of Affective Disorders·R Noyes
Sep 1, 1991·The American Journal of Psychiatry·A T BeckT M Skeie
Sep 1, 1991·Acta Psychiatrica Scandinavica·K TomassonW Coryell
Mar 1, 1989·Acta Psychiatrica Scandinavica·P R Casey
Jan 1, 1986·Annals of the New York Academy of Sciences·A FrancesJ Clarkin
Jan 1, 1988·Acta Psychiatrica Scandinavica. Supplementum·R J DyckH Orn
Feb 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·K Hawton
Jul 1, 1988·Comprehensive Psychiatry·J Morrison, J Herbstein
Jun 1, 1986·The American Journal of Psychiatry·S O LilienfeldH S Akiskal
Nov 1, 1986·The American Journal of Psychiatry·M SwartzR Landerman
Jan 1, 1986·Comprehensive Psychiatry·M Zoccolillo, C R Cloninger
Apr 1, 1984·Archives of General Psychiatry·C DeSouza, E Othmer
Dec 1, 1981·The American Journal of Psychiatry·D S CharneyD M Quinlan
Sep 1, 1994·Psychosomatics·C A Wool, A J Barsky
Dec 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·J SternC Bass
Jan 1, 1993·The American Journal of Psychiatry·G M AsnisJ M Harkavy-Friedman
Aug 1, 1996·The American Journal of Psychiatry·A L BeautraisS K Nightingale
Jan 1, 1995·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·J Angst
Dec 1, 2001·European Psychiatry : the Journal of the Association of European Psychiatrists·Y Lecrubier
Oct 2, 2003·Crisis·Andrea P Chioqueta, Tore C Stiles
Jul 7, 1951·Journal of the American Medical Association·J J PURTELLM E COHEN

❮ Previous
Next ❯

Citations

Oct 12, 2010·Der Nervenarzt·C LahmannA Dinkel
Dec 11, 2008·Psychiatry and Clinical Neurosciences·Erdinç Oztürk, Vedat Sar
Nov 29, 2008·The Journal of Pain : Official Journal of the American Pain Society·Jennifer Brennan Braden, Mark D Sullivan
Sep 25, 2017·Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Österreichischer Nervenärzte und Psychiater·Giancarlo GiupponiAndreas Conca

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.